Trial No.: Genentech GO40554
Trial Name:
A phase I/II study of BTCT4465A in patients who do not achieve CR to 1L therapy for DLBCL and as 1L therapy for patients unfit to receive full-dose anthracycline-based chemotherapy Regulatory Packet sent to Sponsor.
Trial No.: TG Therapeutics UTX-TGR-205
Trial Name:
A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 and TGR-1202 alone in Patients with Previously Treated Diffuse Large B-Cell Lymphoma OPEN COHORTS: MANTLE CELL, FOLICULAR LYMPHOMA
©2018 Fort Wayne Medical Oncology and Hematology. All Rights Reserved.